secwatch.observer — SEC 8-K summary
======================================

Issuer:     HERON THERAPEUTICS, INC. /DE/ (HRTX)
CIK:        0000818033
Form:       8-K
Filed at:   2025-06-18T23:59:59+00:00
Accession:  0000950170-25-087555
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Heron Therapeutics announces 2025 annual meeting results; all proposals approved
--------------------------------------------------------------------------------

- Stockholders elected all six director nominees: Collard, Dissanaike, Johnson, Kaseta, Morgan, Waage, each receiving >79M votes for.
- Ratified WithumSmith+Brown as independent auditor for FY2025: 118.6M votes for, 1.0M against.
- Approved non-binding advisory vote on 2024 executive compensation: 79.3M for, 3.5M against.
- Adopted annual frequency for future say-on-pay advisory votes: 80.5M for 1-year, 2.2M for 3-year.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/818033/000095017025087555/0000950170-25-087555-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/818033/000095017025087555/hrtx-20250612.htm
  HTML page:      https://secwatch.observer/filing/0000950170-25-087555

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer